Nanopharmaceuticals Industry Is Increasingly Recognizing The Potential Of Nanoparticles To Improve Health And Reduce The Incidence Of Diseases
Nanopharmaceuticals can be of different types. One of the types of nanomedicines is Eligard, which serves as a sophisticated drug delivery system for Lupron. The injection form of this product is a liquid that solidifies inside the body and releases the drug over a period of one month. Its biodegradable material allows for the slow release of the drug. Despite its effectiveness, the FDA has approved this product for clinical use in humans. However, the adverse side effects of Eligard include erythema, swelling, and irritation.
With the help of Nanopharmaceuticals, pharmaceutical companies can create personalized medicines based on the results of laboratory tests. These nanomaterials can be tailored to the biomarkers and laboratory tests of individual patients. The combination of these two nanomaterials can enhance the performance of medicine. For this reason, India has a large pool of highly skilled scientists that can translate basic research into effective products. In addition to the FDA-approved products, nanomedicines can also be used to develop customized treatments for patients.
Other examples of Nanopharmaceuticals include Kadcyla and Ontak. Both are nanocrystals and are approved by the FDA. Both types of drugs are available in prescription strength. Some of them are also sold without prescription. They are typically given orally. The FDA has approved these drugs in the United States and other nations. They are increasingly useful as medical products. There is a growing market for these products in the United States, and the growth in their applications is encouraging.
Although the FDA-approved drugs are relatively new, they have shown promise in treating cancer. The FDA has approved a main class of Nanopharmaceuticals with improved efficacy and fewer side effects. The EPR-based nanomedicines can alter the routine pathway of an anti-cancer agent and deliver it directly to the tumor. The benefits of these drugs are so great that the big pharmaceutical companies have put significant resources into these products. In March 2021, European Union (EU) launched an innovative project, Pheonix that focuses on creating an Open Innovation Test Bed for nano-pharmaceutical.
Comments
Post a Comment